Managing Potential Drug Interactions of Nirmatrelvir/Ritonavir in COVID-19 Patients: A Perspective from an Israeli Cross-Sector Collaboration

Shiri Guy-Alfandary, Sasha Zhurat, Maya Berlin, Tal De Haan, Itai Gueta, Renata Shihmanter, Ahuva Golik, Matitiahu Berkovitch, Sara Eyal, Lee H. Goldstein

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)1156-1158
Number of pages3
JournalClinical Pharmacology and Therapeutics
Volume112
Issue number6
DOIs
StatePublished - Dec 2022

Keywords

  • COVID-19 Drug Treatment
  • Drug Interactions
  • Humans
  • Israel/epidemiology
  • Ritonavir/therapeutic use

All Science Journal Classification (ASJC) codes

  • Pharmacology (medical)
  • Pharmacology

Cite this